# NRx Pharmaceuticals (NRXP) — Analyst Forecast

NRXP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nrxp/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 3 | 0 | 0 | 3 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $10.00 | $35.00 | $50.00 | 3 |

Last price $2.71 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 1, 2026 | Ascendiant Capital | Maintained | Buy | $50.00 |
| Sep 14, 2026 | BTIG | Maintained | Buy | $10.00 |
| Aug 25, 2026 | HC Wainwright & Co. | Maintained | Buy | $45.00 |
| Aug 18, 2026 | BTIG | Maintained | Buy | $10.00 |
| Aug 7, 2026 | BTIG | Maintained | Buy | $10.00 |
| May 5, 2026 | D. Boral Capital | Maintained | Buy | $34.00 |
| Apr 27, 2026 | Ascendiant Capital | Maintained | Buy | $49.00 |
| Apr 27, 2026 | HC Wainwright & Co. | Maintained | Buy | $45.00 |
| Apr 23, 2026 | D. Boral Capital | Maintained | Buy | $34.00 |
| Apr 20, 2026 | D. Boral Capital | Maintained | Buy | $34.00 |
| Mar 24, 2026 | BTIG | Maintained | Buy | $25.00 |
| Mar 24, 2026 | D. Boral Capital | Maintained | Buy | $34.00 |
| Mar 17, 2026 | D. Boral Capital | Maintained | Buy | $34.00 |
| Mar 16, 2026 | D. Boral Capital | Maintained | Buy | $34.00 |
| Mar 9, 2026 | D. Boral Capital | Maintained | Buy | $34.00 |
| Mar 3, 2026 | HC Wainwright & Co. | Maintained | Buy | $45.00 |
| Feb 18, 2026 | BTIG | Maintained | Buy | $25.00 |
| Feb 17, 2026 | D. Boral Capital | Maintained | Buy | $34.00 |
| Jan 15, 2026 | BTIG | Maintained | Buy | $25.00 |
| Jan 5, 2026 | D. Boral Capital | Maintained | Buy | $34.00 |

## Frequently Asked Questions

### What is the price target for NRXP stock?

The average 12-month analyst price target for NRx Pharmaceuticals (NRXP) is $35.00, with a high estimate of $50.00 and a low of $10.00, across 3 analysts.

### Is NRXP a buy, sell, or hold?

Analysts covering NRx Pharmaceuticals currently average a Buy rating: 3 buy, 0 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for NRXP?

The average price target of $35.00 implies 1191.51% upside from the last price of $2.71.

### What is the latest analyst rating on NRXP?

On Oct 1, 2026, Ascendiant Capital maintained NRx Pharmaceuticals at Buy with a price target of $50.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).